Mozenavir
Alternative Names: DMP 450; DPC 450; Mozenavir dimesylate; XM 412Latest Information Update: 15 Jul 2002
At a glance
- Originator Bristol-Myers Squibb
- Developer Triangle Pharmaceuticals
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Jul 2002 Discontinued - Phase-II for HIV infections treatment in France (PO)
- 15 Jul 2002 Discontinued - Phase-II for HIV infections treatment in Germany (PO)
- 15 Jul 2002 Discontinued - Phase-II for HIV infections treatment in Mexico (PO)